Production (Stage)
GenSight Biologics S.A.
GSGTF
$0.24
-$0.08-25.00%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -4.35M | -4.48M | -3.15M | -3.17M | -7.67M |
| Total Depreciation and Amortization | 259.00K | 267.10K | 308.40K | 311.00K | 818.70K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 227.10K | 234.20K | -696.40K | -702.40K | 1.22M |
| Change in Net Operating Assets | 878.90K | 906.40K | -417.60K | -421.20K | 1.08M |
| Cash from Operations | -2.98M | -3.07M | -3.95M | -3.99M | -4.55M |
| Capital Expenditure | 0.00 | 0.00 | -500.00 | -500.00 | -5.40K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.70K | 2.70K | 7.00K | 7.10K | 35.50K |
| Cash from Investing | 2.70K | 2.70K | 6.50K | 6.50K | 30.10K |
| Total Debt Issued | -- | -- | -- | -- | 3.09M |
| Total Debt Repaid | -1.24M | -1.24M | -203.50K | -203.50K | -145.50K |
| Issuance of Common Stock | 1.60M | 1.60M | 5.40M | 5.40M | 1.87M |
| Repurchase of Common Stock | -2.50K | -2.50K | -11.00K | -11.00K | -49.50K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 348.50K | 348.50K | 885.00K | 885.00K | -44.00K |
| Cash from Financing | 749.90K | 773.40K | 6.53M | 6.59M | 5.09M |
| Foreign Exchange rate Adjustments | -158.30K | -163.30K | 2.20K | 2.20K | 33.40K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -500.00 |
| Net Change in Cash | -2.39M | -2.46M | 2.59M | 2.61M | 599.10K |